secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164423
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences holds annual meeting; approves officer exculpation charter amendment and 2023 equity plan
--------------------------------------------------------------------------------

- Eight directors elected at June 7 annual meeting: Bencich, Duty, Himes, Jacobs, King, Martell, Sellig, Stewart.
- Stockholders approved amendment to certificate of incorporation to permit officer exculpation under DGCL (9.2M for, 162k against).
- Auditors PricewaterhouseCoopers LLP ratified for FY2023 (13.9M for, 93k against).
- Non-binding advisory vote on executive compensation passed; future say-on-pay votes every three years.
- 2023 Non-Employee Director Equity Incentive Plan approved (8.4M for, 898k against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000119312523164423/0001193125-23-164423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000119312523164423/d503566d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer